A confirmed or probable etiology can be identified in 30% to 60% of acute childhood encephalitis cases. The most common infectious causes in otherwise healthy Canadian children are HSV, varicella zoster virus (VZV), Epstein Barr virus (EBV), M pneumoniae and influenza, adenovirus and other respiratory viruses (Table 2) . Arboviruses endemic to North America and entero-/parechoviruses are important considerations during the summer and fall months (7) (8) (9) (10) , whereas influenza and other respiratory viruses are more typically observed during the winter months. M pneumoniae encephalitis can be observed year-round, with increased incidence coinciding with epidemic respiratory disease every three to seven years (11) . Less commonly encountered pathogens include measles, mumps, rabies, Bartonella henselae, Baylisascaris procyonis and travel-related arboviruses, Rickettsia and free-living amoebae. ADEM and anti-NMDAR encephalitis are the predominant noninfectious causes of encephalitis in children, together accounting for approximately 15% to 25% of all encephalitis cases, respectively (3, 12) . A review of cases involving patients <30 years of age referred to the California Encephalitis Project suggested that the frequency of anti-NMDAR encephalitis was higher than any single viral etiology (12) . The main causes of subacute encephalitis in children are shown in Table 3 .
In
the immunocompromised host, herpes-group viruses (including HSV, VZV, EBV, cytomegalovirus and human herpes virus-6 [HHV-6]), enteroviruses and polyoma JC virus (progressive multifocal pediAtric infectious diseAses notes
This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http:// creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. For commercial reuse, contact support@pulsus.com (13, 14) . Encephalitis due to West Nile virus and rabies has been observed in adults following organ transplantation from an infected donor (15,16).
Travel-related viral encephalitides, not endemic to Canada, should be considered if symptom onset began within three to four weeks of leaving the region (1) (2) (3) 17) . Japanese encephalitis virus, endemic to Japan, Korea, Taiwan, China, Southeast Asia, India, Nepal and northern Australia, is a predominant travel-related pathogen (18) . Rural travel during the summer months to central or northern Europe or Russia, including Siberia, should lead to consideration of tick-borne encephalitis virus. Nipah virus infection is acquired following close contact with swine, bats or bat roosting sites, or infected Absence of a respiratory prodrome does not preclude as a cause. Both direct and immune-mediated pathogenesis hypothesized. PCR of CSF and respiratory samples plus serology in peripheral blood recommended for diagnosis; due to poor specificity and predictive value, serology should not be relied upon in isolation for diagnosis. Treatment: A 10-14 day course of antimycoplasmal antibiotic therapy may be considered; role of corticosteroids uncertain
Bartonella henselae
Consider in those with exposure to cats. Serology is the mainstay of microbiological diagnosis. PCR available, but utility in diagnosis of encephalopathy/encephalitis unknown. Treatment: doxycycline or cotrimoxazole plus rifampin for 4-6 weeks may be considered Baylisascaris procyonis (19) Consider in toddlers or cognitively impaired children with exposure to soil potentially contaminated with raccoon feces. Peripheral blood and CSF eosinophilia. Serology is the mainstay of microbiological diagnosis. Treatment: albendazole for 4 weeks plus corticosteroids with taper may be of benefit The microbiological investigation of the previously well child with acute encephalitis need not be exhaustive and should be tailored to the history and findings on physical examination (1-3) . PCR testing of CSF for HSV, EBV, entero-/parechoviruses and M pneumoniae and of respiratory samples for M pneumoniae and entero-/parechoviruses is recommended for all cases. Stool should be tested for enteroviruses and adenovirus. Serology on peripheral blood for acute EBV and M pneumoniae infection should also be performed, and an acute serum sample stored for subsequent testing for less commonly encountered pathogens (1) . Serological testing of serum and CSF for West Nile virus and other endemic arboviruses should be performed when disease onset is during the summer and fall months. In the presence of respiratory symptoms, respiratory samples should be tested for influenza A and B, adenoviruses, parainfluenza viruses, respiratory syncytial virus and rhinoviruses. A vesicular rash should prompt testing of lesion samples for HSV, VZV and selectively for enteroviruses by PCR (or culture). Serology and PCR testing of CSF as well as respiratory or salivary samples for measles and mumps is warranted in children with suggestive clinical findings. Baylisascaris procyonis serology is appropriate for toddlers or autistic/developmentally delayed children with peripheral or CSF eosinophilia, particularly if there is a history of pica or playing in soil frequented by raccoons (19) . In case of travel, a detailed history that includes precise travel dates, specific regions visited (rural versus urban), any documented exposures to arbovirus vectors, animals (including bites or scratches), or swimming in lakes and brackish water should direct testing for travel-related infections (1-3) .
*The 2012 Red Book recommends a dose of 30-45 mg/kg/day in three divided dose for children three months to 12 years of age. However, some experts prefer to use the upper limit of the approved dose range (60 mg/kg/day in three divided doses) for children <12 years of age; close monitoring of renal function is required; † In adults, herpes zoster-associated encephalitis predominates (mainly in immunocompromised hosts); ‡ Some experts prefer to use 1500 mg/m 2 /day in three divided doses, the dose usually used to treat varicella in immunocompromised hosts; duration of therapy has not been well established, and close monitoring of renal function is required; § Eastern equine and Powassan encephalitis viruses are a consideration primarily in the eastern provinces; Western equine encephalitis predominantly in the western and prairie provinces and into Ontario; St Louis and the California serogroup viruses (Snowshoe hare and Jamestown Canyon) encephalitis viruses are more ubiquitous; ¶ Other respiratory viruses, including adenovirus, parainfluenza viruses and respiratory syncytial virus, are occasionally associated with encephalitis or infection-associated encephalopathy. CSF Cerebrospinal fluid; EA Early antigen; EBNA Epstein Barr nuclear antigen; EBV Epstein Barr virus; HHV-6 Human herpes virus-6; HHV-7 Human herpes virus-7; HSV Herpes simplex virus; Ig Immunoglobulin; IVIG Intravenous immunoglobulin; MRI Magnetic resonance imaging; NMDAR N-methyl-D-aspartate receptor; PCR Polymerase chain reaction; RT-PCR
Treatment of acute childhood encephalitis begins with meticulous supportive care that includes management of fluid and electrolytes, respiratory status, seizures and increased intracranial pressure. Intravenous acyclovir should be given to all children pending microbiological test results (Table 2) . A full three-week course of therapy should be administered if HSV disease is confirmed or if the clinical picture is most compatible with HSV encephalitis regardless of PCR results, particularly if the lumbar puncture was performed within 72 h of symptom onset. Treatment directed at other pathogens should be considered, although efficacy is less well established (Table 2) . Firstline therapy for ADEM and anti-NMDAR encephalitis consists of high-dose corticosteroids; other treatment modalities include intravenous immunoglobulin, plasma exchange and, for refractory cases of anti-NMDAR encephalitis, rituximab (20) . Excision of ovarian teratoma or other tumours associated with anti-NMDAR encephalitis speeds up clinical response and reduces relapses (21) .
The risk for death and permanent neurological sequelae including cognitive impairment, psychiatric or behavioural disorders, epilepsy, motor dysfunction, cranial nerve deficits or movement disorders vary according to etiology. Rabies encephalitis, subacute sclerosing panencephalitis, measles inclusion-body encephalitis, rubella panencephalitis and non-HIV-associated progressive multifocal leukoencephalopathy are almost uniformly fatal. Although mortality is now uncommon, neurological sequelae occur in 50% to 60% or more of children with HSV encephalitis despite acyclovir treatment (22) . The outcome of M pneumoniae-associated encephalitis is similarly poor, with 50% to 60% of children experiencing sequelae (23) . Death or neurological sequelae following arboviral encephalitis varies from 50% to 70% for Eastern equine and Powassan encephalitis to 10% to 30% for Japanese, St Louis, Western equine and La Crosse encephalitis (8) (9) (10) 18) . Most children with ADEM respond to immune-modulation, but approximately 20% experience relapses, some of whom are eventually diagnosed with multiple sclerosis. With appropriate treatment, 85% of children with anti-NMDAR encephalitis demonstrate either complete recovery (60%) or minimal residual deficits (25%) (6) .
Significant challenges remain in the diagnosis and management of childhood encephalitis. Standardizing diagnostic algorithms and enhancing the microbiological investigative capability of laboratories around the country would be an important first step in enhancing diagnostic yield. Future research needs include discovery of new infectious and noninfectious causes, improving our understanding of pathogenesis and determining optimal etiology-specific therapeutic regimens. 
